CHK2 kinase in the DNA damage response and beyond

Area of Science:

• Molecular Biology
• Cell Biology
• Genetics

Background:

• The serine/threonine kinase CHK2 is a central regulator of the DNA damage response pathway in human cells.
• CHK2 activation leads to phosphorylation of over 20 substrates, orchestrating cellular outcomes like cell cycle arrest, apoptosis, senescence, or DNA repair.
• Emerging evidence highlights CHK2's roles in DNA structure modification and cell cycle progression, independent of DNA damage.

Purpose of the Study:

• To review the dual functions of CHK2: its role in DNA damage response and its activities in unstressed cells.
• To explore the implications of CHK2's functions in tumorigenesis.
• To discuss CHK2 as a potential therapeutic target in cancer treatment.

Main Methods:

• Literature review of CHK2's functions in DNA damage response.
• Analysis of studies investigating CHK2's roles in unstressed cells.
• Synthesis of information regarding CHK2's involvement in cancer and therapeutic strategies.

Main Results:

• CHK2 activation is a critical step in the cellular response to genotoxic stress, mediating diverse outcomes.
• CHK2 exhibits functions beyond DNA damage response, influencing normal cell cycle progression and DNA structure.
• Dysregulation of CHK2 is implicated in tumorigenesis, suggesting its potential as a cancer therapy target.

Conclusions:

• CHK2 is a versatile kinase with essential roles in both DNA damage response and fundamental cellular processes.
• Understanding CHK2's multifaceted activities is crucial for comprehending its role in cancer.
• Targeting CHK2 may offer a promising avenue for novel cancer therapies.